MERIDIAN BIOSCIENCE INC — DEFA14A

MERIDIAN BIOSCIENCE INC of CINCINNATI, OH filed a DEFA14A with the SEC on 2022-07-07. Industry: In Vitro & In Vivo Diagnostic Substances.

Filing

Documents (1)

SeqTypeDescription
1DEFA14ADEFA14A

Filing timeline for this registrant (46)

Showing 12 of 46 filings.

FiledForm
2022-09-30DEFA14A
2022-09-08DEFM14A
2022-08-25PREM14A
2022-07-08DEFA14A
2022-07-07DEFA14A
2022-07-07DEFA14A
2022-07-07DEFA14A
2022-07-07DEFA14A
2021-12-15DEFA14A
2021-12-15DEF 14A
2021-01-12DEFA14A
2020-12-30DEFA14A

More